| Year |
Citation |
Score |
| 2024 |
Kotnala S, Dhasmana A, Dhasmana S, Haque S, Yallapu MM, Tripathi MK, Jaggi M, Chauhan SC. A Systems Biology Approach Unveils a Critical Role of DPP4 in Upper Gastrointestinal Cancer Patient Outcomes. Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society For Environmental Toxicology and Cancer. 43: 43-55. PMID 38505912 DOI: 10.1615/JEnvironPatholToxicolOncol.2023048056 |
0.439 |
|
| 2024 |
Malik S, Sikander M, Wahid M, Dhasmana A, Sarwat M, Khan S, Cobos E, Yallapu MM, Jaggi M, Chauhan SC. Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance. Cancer Metastasis Reviews. PMID 38498072 DOI: 10.1007/s10555-024-10177-8 |
0.429 |
|
| 2024 |
Ghali ENHK, Chauhan SC, Yallapu MM. Inulin-based formulations as an emerging therapeutic strategy for cancer: A comprehensive review. International Journal of Biological Macromolecules. 129216. PMID 38185294 DOI: 10.1016/j.ijbiomac.2024.129216 |
0.376 |
|
| 2023 |
Dhasmana S, Dhasmana A, Rios S, Enriquez-Perez IA, Khan S, Afaq F, Haque S, Manne U, Yallapu MM, Chauhan SC. An integrated computational biology approach defines the crucial role of TRIP13 in pancreatic cancer. Computational and Structural Biotechnology Journal. 21: 5765-5775. PMID 38074464 DOI: 10.1016/j.csbj.2023.11.029 |
0.342 |
|
| 2023 |
Afaq F, Agarwal S, Bajpai P, Diffalha SA, Kim HG, Peter S, Khushman M, Chauhan SC, Mukherjee P, Varambally S, Manne U. Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma. Neoplasia (New York, N.Y.). 47: 100951. PMID 38039923 DOI: 10.1016/j.neo.2023.100951 |
0.324 |
|
| 2023 |
Sikander M, Malik S, Apraku J, Kumari S, Khan P, Mandil H, Ganju A, Chauhan B, Bell MC, Singh MM, Khan S, Yallapu MM, Halaweish FT, Jaggi M, Chauhan SC. Synthesis and Antitumor Activity of Brominated-Ormeloxifene (Br-ORM) against Cervical Cancer. Acs Omega. 8: 38839-38848. PMID 37901538 DOI: 10.1021/acsomega.3c02277 |
0.36 |
|
| 2023 |
Doxtater K, Tripathi MK, Sekhri R, Hafeez BB, Khan S, Zafar N, Behrman SW, Yallapu MM, Jaggi M, Chauhan SC. MUC13 drives cancer aggressiveness and metastasis through the YAP1-dependent pathway. Life Science Alliance. 6. PMID 37793774 DOI: 10.26508/lsa.202301975 |
0.447 |
|
| 2023 |
Laskar P, Dhasmana A, Kotnala S, Jaggi M, Yallapu MM, Chauhan SC. Glutathione-Responsive Tannic Acid-Assisted FRET Nanomedicine for Cancer Therapy. Pharmaceutics. 15. PMID 37242568 DOI: 10.3390/pharmaceutics15051326 |
0.352 |
|
| 2023 |
Dhasmana A, Dhasmana S, Agarwal S, Khan S, Haque S, Jaggi M, Yallapu MM, Chauhan SC. Integrative big transcriptomics data analysis implicates crucial role of MUC13 in pancreatic cancer. Computational and Structural Biotechnology Journal. 21: 2845-2857. PMID 37216018 DOI: 10.1016/j.csbj.2023.04.029 |
0.323 |
|
| 2023 |
Chauhan N, Cabrera M, Chowdhury P, Nagesh PKB, Dhasmana A, Jaggi M, Chauhan SC, Yallapu MM. Indocyanine Green-based Glow Nanoparticles Probe for Cancer Imaging. Nanotheranostics. 7: 353-367. PMID 37151801 DOI: 10.7150/ntno.78405 |
0.37 |
|
| 2023 |
Dhasmana A, Dhasmana S, Kotnala S, Laskar P, Khan S, Haque S, Jaggi M, Yallapu MM, Chauhan SC. CEACAM7 expression contributes to early events of pancreatic cancer. Journal of Advanced Research. PMID 36828119 DOI: 10.1016/j.jare.2023.02.013 |
0.341 |
|
| 2022 |
Laskar P, Jaggi M, Chauhan SC, Yallapu MM. Biomolecule-functionalized nanoformulations for prostate cancer theranostics. Journal of Advanced Research. PMID 36368516 DOI: 10.1016/j.jare.2022.11.001 |
0.361 |
|
| 2022 |
Chowdhury P, Bhusetty Nagesh PK, Hollingsworth TJ, Jaggi M, Chauhan SC, Yallapu MM. Coating a Self-Assembly Nanoconstruct with a Neutrophil Cell Membrane Enables High Specificity for Triple Negative Breast Cancer Treatment. Acs Applied Bio Materials. PMID 35976626 DOI: 10.1021/acsabm.2c00614 |
0.326 |
|
| 2022 |
Parashar D, Singh A, Gupta S, Sharma A, Sharma MK, Roy KK, Chauhan SC, Kashyap VK. Emerging Roles and Potential Applications of Non-Coding RNAs in Cervical Cancer. Genes. 13. PMID 35886037 DOI: 10.3390/genes13071254 |
0.345 |
|
| 2022 |
Hatami E, B Nagesh PK, Sikander M, Dhasmana A, Chauhan SC, Jaggi M, Yallapu MM. Tannic Acid Exhibits Antiangiogenesis Activity in Nonsmall-Cell Lung Cancer Cells. Acs Omega. 7: 23939-23949. PMID 35847334 DOI: 10.1021/acsomega.2c02727 |
0.331 |
|
| 2022 |
Kashyap VK, Peasah-Darkwah G, Dhasmana A, Jaggi M, Yallapu MM, Chauhan SC. : Progress towards a Pharmaceutical Agent for Immunomodulation and Cancer Therapeutics. Pharmaceutics. 14. PMID 35335986 DOI: 10.3390/pharmaceutics14030611 |
0.405 |
|
| 2021 |
Kumari S, Sikander M, Malik S, Tripathi MK, Hafeez BB, Yallapu MM, Chauhan SC, Khan S, Jaggi M. Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer Cells. Biomedicines. 9. PMID 34944630 DOI: 10.3390/biomedicines9121814 |
0.395 |
|
| 2021 |
Dhasmana A, Dhasmana S, Kotnala S, A A, Kashyap VK, Shaji PD, Laskar P, Khan S, Pellicano R, Fagoonee S, Haque S, Yallapu MM, Chauhan SC, Jaggi M. A topography of immunotherapies against gastrointestinal malignancies. Panminerva Medica. PMID 34664484 DOI: 10.23736/S0031-0808.21.04541-9 |
0.419 |
|
| 2021 |
Chowdhury P, Ghosh U, Samanta K, Jaggi M, Chauhan SC, Yallapu MM. Bioactive nanotherapeutic trends to combat triple negative breast cancer. Bioactive Materials. 6: 3269-3287. PMID 33778204 DOI: 10.1016/j.bioactmat.2021.02.037 |
0.331 |
|
| 2021 |
Chauhan DS, Dhasmana A, Laskar P, Prasad R, Jain NK, Srivastava R, Jaggi M, Chauhan SC, Yallapu MM. Nanotechnology Synergised Immunoengineering for Cancer. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 33774162 DOI: 10.1016/j.ejpb.2021.03.010 |
0.337 |
|
| 2020 |
Hatami E, Nagesh PKB, Jaggi M, Chauhan SC, Yallapu MM. Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancer. European Journal of Pharmacology. 173486. PMID 32805254 DOI: 10.1016/j.ejphar.2020.173486 |
0.357 |
|
| 2020 |
Chaib M, Chauhan SC, Makowski L. Friend or Foe? Recent Strategies to Target Myeloid Cells in Cancer. Frontiers in Cell and Developmental Biology. 8: 351. PMID 32509781 DOI: 10.3389/fcell.2020.00351 |
0.309 |
|
| 2020 |
Hatami E, Jaggi M, Chauhan SC, Yallapu MM. Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics. Biochimica Et Biophysica Acta. Reviews On Cancer. 1874: 188381. PMID 32492470 DOI: 10.1016/j.bbcan.2020.188381 |
0.391 |
|
| 2020 |
Choi YD, Jung JY, Baek M, Khan S, Song PI, Ryu S, Koo JY, Chauhan SC, Tsin A, Choi C, Kim WJ, Kim M. APE1 Promotes Pancreatic Cancer Proliferation through GFRα1/Src/ERK Axis-Cascade Signaling in Response to GDNF. International Journal of Molecular Sciences. 21. PMID 32438692 DOI: 10.3390/ijms21103586 |
0.46 |
|
| 2020 |
Shetty A, Nagesh PKB, Setua S, Hafeez BB, Jaggi M, Yallapu MM, Chauhan SC. Novel Paclitaxel Nanoformulation Impairs De Novo Lipid Synthesis in Pancreatic Cancer Cells and Enhances Gemcitabine Efficacy. Acs Omega. 5: 8982-8991. PMID 32337462 DOI: 10.1021/acsomega.0c00793 |
0.321 |
|
| 2020 |
Ranjit S, Kodidela S, Sinha N, Chauhan S, Kumar S. Extracellular Vesicles from Human Papilloma Virus-Infected Cervical Cancer Cells Enhance HIV-1 Replication in Differentiated U1 Cell Line. Viruses. 12. PMID 32098055 DOI: 10.3390/V12020239 |
0.316 |
|
| 2020 |
Chauhan N, Kruse A, Newby H, Jaggi M, Yallapu MM, Chauhan SC. Pluronic Polymer-Based Ormeloxifene Nanoformulations Induce Superior Anticancer Effects in Pancreatic Cancer Cells. Acs Omega. 5: 1147-1156. PMID 31984272 DOI: 10.1021/acsomega.9b03382 |
0.357 |
|
| 2020 |
Massey AE, Doxtater KA, Yallapu MM, Chauhan SC. Biophysical changes caused by altered MUC13 expression in pancreatic cancer cells. Micron (Oxford, England : 1993). 130: 102822. PMID 31927412 DOI: 10.1016/j.micron.2019.102822 |
0.4 |
|
| 2020 |
Doxtater K, Sekhri R, Mishra U, Jaggi M, Tripathi M, Chauhan S. Abstract 4916: MUC13 enhances anchorage independent survival and cooperates with YAP1 and β-catenin towards colorectal cancer metastasis Tumor Biology. DOI: 10.1158/1538-7445.Am2020-4916 |
0.42 |
|
| 2020 |
Doxtater K, Zacheaus C, Sekhri R, Mishra UK, Stiles ZE, Mishra N, Guda C, Zafar N, Amin M, Shukla P, Yallapu MM, Jaggi M, Chauhan SC, Tripathi MK. Abstract 3142: Stress regulated role of lncRNA Malat1 in colorectal cancer progression and metastasis Clinical Trials. 80: 3142-3142. DOI: 10.1158/1538-7445.Am2020-3142 |
0.435 |
|
| 2019 |
Sikander M, Malik S, Khan S, Kumari S, Chauhan N, Khan P, Halaweish FT, Chauhan B, Yallapu MM, Jaggi M, Chauhan SC. Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pancreatic Cancer). Cells. 9. PMID 31906106 DOI: 10.3390/Cells9010103 |
0.438 |
|
| 2019 |
Adhikari P, Nagesh PKB, Alharthi F, Chauhan SC, Jaggi M, Yallapu MM, Pradhan P. Optical detection of the structural properties of tumor tissue generated by xenografting of drug-sensitive and drug-resistant cancer cells using partial wave spectroscopy (PWS). Biomedical Optics Express. 10: 6422-6431. PMID 31853408 DOI: 10.1364/BOE.10.006422 |
0.302 |
|
| 2019 |
Kashyap VK, Dan N, Chauhan N, Wang Q, Setua S, Nagesh PKB, Malik S, Batra V, Yallapu MM, Miller DD, Li W, Hafeez BB, Jaggi M, Chauhan SC. VERU-111 suppresses tumor growth and metastatic phenotypes of cervical cancer cells through the activation of p53 signaling pathway. Cancer Letters. PMID 31809801 DOI: 10.1016/j.canlet.2019.11.035 |
0.432 |
|
| 2019 |
Samanta K, Setua S, Kumari S, Jaggi M, Yallapu MM, Chauhan SC. Gemcitabine Combination Nano Therapies for Pancreatic Cancer. Pharmaceutics. 11. PMID 31689930 DOI: 10.3390/pharmaceutics11110574 |
0.357 |
|
| 2019 |
Chauhan N, Maher DM, Hafeez BB, Mandil H, Singh MM, Yallapu MM, Jaggi M, Chauhan SC. Ormeloxifene nanotherapy for cervical cancer treatment. International Journal of Nanomedicine. 14: 7107-7121. PMID 31564868 DOI: 10.2147/Ijn.S200944 |
0.439 |
|
| 2019 |
Nagesh PKB, Chowdhury P, Hatami E, Kumari S, Kashyap VK, Tripathi MK, Wagh S, Meibohm B, Chauhan SC, Jaggi M, Yallapu MM. Cross linked polyphenol-based drug nano-self assemblies engineered to blockade prostate cancer senescence. Acs Applied Materials & Interfaces. PMID 31553876 DOI: 10.1021/Acsami.9B14738 |
0.405 |
|
| 2019 |
Chauhan N, Maher DM, Yallapu MM, B Hafeez B, Singh MM, Chauhan SC, Jaggi M. A triphenylethylene nonsteroidal SERM attenuates cervical cancer growth. Scientific Reports. 9: 10917. PMID 31358785 DOI: 10.1038/S41598-019-46680-0 |
0.424 |
|
| 2019 |
Massey AE, Sikander M, Chauhan N, Kumari S, Setua S, Shetty AB, Mandil H, Kashyap VK, Khan S, Jaggi M, Yallapu MM, Hafeez BB, Chauhan SC. Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. Nanomedicine : Nanotechnology, Biology, and Medicine. 102027. PMID 31170509 DOI: 10.1016/J.Nano.2019.102027 |
0.486 |
|
| 2019 |
Khan S, Setua S, Kumari S, Dan N, Massey A, Hafeez BB, Yallapu MM, Stiles ZE, Alabkaa A, Yue J, Ganju A, Behrman S, Jaggi M, Chauhan SC. Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer. Biomaterials. 208: 83-97. PMID 30999154 DOI: 10.1016/J.Biomaterials.2019.04.005 |
0.461 |
|
| 2019 |
Sikander M, Malik S, Chauhan N, Khan P, Kumari S, Kashyap VK, Khan S, Ganju A, Halaweish FT, Yallapu MM, Jaggi M, Chauhan SC. Cucurbitacin D Reprograms Glucose Metabolic Network in Prostate Cancer. Cancers. 11. PMID 30875788 DOI: 10.3390/Cancers11030364 |
0.361 |
|
| 2019 |
Kashyap VK, Wang Q, Setua S, Nagesh PKB, Chauhan N, Kumari S, Chowdhury P, Miller DD, Yallapu MM, Li W, Jaggi M, Hafeez BB, Chauhan SC. Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer. Journal of Experimental & Clinical Cancer Research : Cr. 38: 29. PMID 30674344 DOI: 10.1186/S13046-018-1009-7 |
0.525 |
|
| 2019 |
Setua S, Khan S, Dan N, Yallapu MM, Kumari S, Behrman SW, Jaggi M, Chauhan SC. Abstract 990: Improving TRAIL therapy response in pancreatic cancer by replenishment of miR-145 Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-990 |
0.363 |
|
| 2019 |
Chauhan N, Yallapu MM, Maher DM, Hafeez BB, Sikander M, Jaggi M, Chauhan S. Abstract 3636: Generation of polymeric nanoformulation of ormeloxifene for cervical cancer treatment Cancer Research. 79: 3636-3636. DOI: 10.1158/1538-7445.Sabcs18-3636 |
0.556 |
|
| 2019 |
Chaib M, Hafeez BB, Kumari S, Sikander M, Mandil H, Makowski L, Pingili AK, Hatami E, Shetty A, Nirnoy D, Yallapu MM, Jaggi M, Chauhan S. Abstract 102: Ferrichrome suppresses pancreatic tumor growth via targeting TAMs and enhancing CD8+ T-cells infiltration Cancer Research. 79: 102-102. DOI: 10.1158/1538-7445.Sabcs18-102 |
0.413 |
|
| 2019 |
Sikander M, Malik S, Hafeez BB, Kumari S, Khan S, Apraku J, Mandil H, Massey AE, Ganju A, Khan P, Halaweish FT, Chauhan SC, Jaggi M. Abstract 4809: Bromo-ormeloxifene inhibits epithelial mesenchymal transitionviatargeting β-catenin signaling pathways in cervical cancer cells Cancer Research. 79: 4809-4809. DOI: 10.1158/1538-7445.Am2019-4809 |
0.499 |
|
| 2019 |
Kumari S, Khan S, Yallapu M, Chauhan S, Jaggi M. Abstract 4367: Protein kinase D1 induces metabolic switch in pancreatic cancerviamodulation of mTORC1 Cancer Research. 79: 4367-4367. DOI: 10.1158/1538-7445.Am2019-4367 |
0.419 |
|
| 2019 |
Nagesh PKB, Chowdhury P, Hatami E, Kumari S, Kashyap VK, Hafeez B, Khan S, Tripathi MK, Jaggi M, Chauhan SC, Yallapu MM. Abstract 3634: Tannic acid-docetaxel scaffold nanoparticles for improved prostate cancer therapy Cancer Research. 79: 3634-3634. DOI: 10.1158/1538-7445.Am2019-3634 |
0.478 |
|
| 2019 |
Dan N, Khan S, Setua S, Kumari S, Chowdhury P, Samanta K, Jaggi M, Yallappu M, Chauhan S. Abstract 3625: Nanodelivery platform for targeting mutant-KRAS and improving response to gemcitabine therapy Cancer Research. 79: 3625-3625. DOI: 10.1158/1538-7445.Am2019-3625 |
0.499 |
|
| 2019 |
Kashyap VK, Hafeez BB, Wang Q, Chauhan N, Nagesh PK, Yallapu MM, Miller DD, Li W, Jaggi M, Chauhan SC. Abstract 3619: Nanoparticle formulation of VERU 111 for pancreatic cancer treatment Cancer Research. 79: 3619-3619. DOI: 10.1158/1538-7445.Am2019-3619 |
0.555 |
|
| 2019 |
Doxtater K, Zacheaus C, Keramatnia F, Chaib M, Triparthi M, Chauhan S. Abstract 2647: MUC13 interacts with SOX2 leading to cell stemness and Anoikis resistance in colorectal cancer Cancer Research. 79: 2647-2647. DOI: 10.1158/1538-7445.Am2019-2647 |
0.505 |
|
| 2019 |
Hatami E, Nagesh PKB, Chowdhury P, Shetty AB, Tripathi MK, Chauhan S, Jaggi M, Yallapu M. Abstract 1871: Tannic acid: A natural anticancer agent for non-small cell lung cancer Cancer Research. 79: 1871-1871. DOI: 10.1158/1538-7445.Am2019-1871 |
0.498 |
|
| 2019 |
Rath S, Gandhi AK, Rastogi M, Pandey A, Noman K, Masood S, Chauhan S, Nanda SS, Singh HB, Khurana R, Hadi R, Bharati A, Srivastva AK. Long Course Neoadjuvant Concurrent Chemo-Radiotherapy with or Without Pre-Radiation Induction Chemotherapy in the Management of Rectal Cancers: A Mono-Institutional Retrospective Analysis International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.2160 |
0.362 |
|
| 2018 |
Chowdhury P, Nagesh PKB, Hatami E, Wagh S, Dan N, Tripathi MK, Khan S, Hafeez BB, Meibohm B, Chauhan SC, Jaggi M, Yallapu MM. Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells. Journal of Colloid and Interface Science. 535: 133-148. PMID 30292104 DOI: 10.1016/J.Jcis.2018.09.072 |
0.408 |
|
| 2018 |
Tripathi MK, Zacheaus C, Doxtater K, Keramatnia F, Gao C, Yallapu MM, Jaggi M, Chauhan SC. Z Probe, An Efficient Tool for Characterizing Long Non-Coding RNA in FFPE Tissues. Non-Coding Rna. 4. PMID 30189670 DOI: 10.3390/Ncrna4030020 |
0.432 |
|
| 2018 |
Nagesh PKB, Chowdhury P, Hatami E, Boya VKN, Kashyap VK, Khan S, Hafeez BB, Chauhan SC, Jaggi M, Yallapu MM. miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy. Cancers. 10. PMID 30149628 DOI: 10.3390/Cancers10090289 |
0.443 |
|
| 2018 |
Chowdhury P, Nagesh PKB, Khan S, Hafeez BB, Chauhan SC, Jaggi M, Yallapu MM. Development of polyvinylpyrrolidone/paclitaxel self-assemblies for breast cancer. Acta Pharmaceutica Sinica. B. 8: 602-614. PMID 30109184 DOI: 10.1016/J.Apsb.2017.10.004 |
0.429 |
|
| 2018 |
Hatami E, Nagesh PKB, Chowdhury P, Chauhan SC, Jaggi M, Samarasinghe AE, Yallapu MM. Tannic Acid-Lung Fluid Assemblies Promote Interaction and Delivery of Drugs to Lung Cancer Cells. Pharmaceutics. 10. PMID 30071698 DOI: 10.3390/Pharmaceutics10030111 |
0.377 |
|
| 2018 |
Almabadi HM, Nagesh PKB, Sahay P, Bhandari S, Eckstein EC, Jaggi M, Chauhan SC, Yallappu MM, Pradhan P. Optical study of chemotherapy efficiency in cancer treatment via intracellular structural disorder analysis using partial wave spectroscopy. Journal of Biophotonics. e201800056. PMID 29869394 DOI: 10.1002/Jbio.201800056 |
0.439 |
|
| 2018 |
Tripathi MK, Doxtater K, Keramatnia F, Zacheaus C, Yallapu MM, Jaggi M, Chauhan SC. Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes. Drug Discovery Today. PMID 29698834 DOI: 10.1016/J.Drudis.2018.04.010 |
0.449 |
|
| 2018 |
Dan N, Setua S, Kashyap VK, Khan S, Jaggi M, Yallapu MM, Chauhan SC. Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications. Pharmaceuticals (Basel, Switzerland). 11. PMID 29642542 DOI: 10.3390/Ph11020032 |
0.436 |
|
| 2018 |
Nagesh PKB, Hatami E, Chowdhury P, Kashyap VK, Khan S, Hafeez BB, Chauhan SC, Jaggi M, Yallapu MM. Tannic Acid Induces Endoplasmic Reticulum Stress-Mediated Apoptosis in Prostate Cancer. Cancers. 10. PMID 29518944 DOI: 10.3390/Cancers10030068 |
0.409 |
|
| 2018 |
Awasthee N, Rai V, Chava S, Nallasamy P, Kunnumakkara AB, Bishayee A, Chauhan SC, Challagundla KB, Gupta SC. Targeting IκappaB kinases for cancer therapy. Seminars in Cancer Biology. PMID 29486318 DOI: 10.1016/J.Semcancer.2018.02.007 |
0.4 |
|
| 2018 |
Ganju A, Chauhan SC, Hafeez BB, Doxtater K, Tripathi MK, Zafar N, Yallapu MM, Kumar R, Jaggi M. Protein kinase D1 regulates subcellular localisation and metastatic function of metastasis-associated protein 1. British Journal of Cancer. 118: 587-599. PMID 29465084 DOI: 10.1038/Bjc.2017.431 |
0.388 |
|
| 2018 |
Khan S, Zafar N, Khan SS, Setua S, Behrman SW, Stiles ZE, Yallapu MM, Sahay P, Ghimire H, Ise T, Nagata S, Wang L, Wan JY, Pradhan P, Jaggi M, ... Chauhan SC, et al. Clinical significance of MUC13 in pancreatic ductal adenocarcinoma. Hpb : the Official Journal of the International Hepato Pancreato Biliary Association. PMID 29352660 DOI: 10.1016/J.Hpb.2017.12.003 |
0.404 |
|
| 2018 |
Hatami E, Nagesh PKB, Chowdhury P, Kashyap VK, Khan S, Hafeez B, Jaggi M, Chauhan SC, Yallapu MM. Abstract LB-400: Tannic acid induces prostate cancer cell death via unfolded protein response (UPR) and modulation of CHOP Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-400 |
0.432 |
|
| 2018 |
Hafeez BB, Massey AE, Kashyap VK, Sikander M, Shetty A, Chaib M, Mandil H, Yallapu M, Jaggi M, Chauhan SC. Abstract LB-011: Novel nano-formulation of paclitaxel for pancreatic cancer therapy Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-011 |
0.526 |
|
| 2018 |
Tripathi MK, Zacheaus C, Doxtater K, Stiles Z, Keramatnia F, Zafar N, Amin M, Jaggi M, Chauhan S. Abstract 5178: MUC13 is a novel molecular signature, for early detection and metastatic colorectal cancer Cancer Research. 78: 5178-5178. DOI: 10.1158/1538-7445.Am2018-5178 |
0.463 |
|
| 2018 |
Nagesh PKB, Chowdhury P, Hatami E, Kashyap VK, Hafeez BB, Khan S, Chauhan SC, Jaggi M, Yallapu MM. Abstract 4657: Docetaxel nanoformulation reverts drug resistance in prostate cancer Cancer Research. 78: 4657-4657. DOI: 10.1158/1538-7445.Am2018-4657 |
0.429 |
|
| 2018 |
Sikander M, Malik S, Hafeez BB, Mandil H, Halaweish FT, Jaggi M, Chauhan SC. Abstract 2934: Cucurbitacin D enhances the therapeutic efficacy of docetaxel via targeting cancer stem cells and miR-145 Cancer Research. 78: 2934-2934. DOI: 10.1158/1538-7445.Am2018-2934 |
0.464 |
|
| 2018 |
Setua S, Khan S, Yallapu M, Kumari S, Jaggi M, Chauhan SC. Abstract 2110: Therapeutic intervention for pancreatic cancer using autologous exosomes Cancer Research. 78: 2110-2110. DOI: 10.1158/1538-7445.Am2018-2110 |
0.513 |
|
| 2018 |
Khan SS, Doxtater K, Kumari S, Setua S, Sikander M, Malik S, Yallapu M, Behrman S, Chauhan S, Jaggi M. Abstract 198: MUC13 promotes pancreatic tumor-stromal interactions by influencing tumor microenvironment Cancer Research. 78: 198-198. DOI: 10.1158/1538-7445.Am2018-198 |
0.464 |
|
| 2018 |
Pandey A, Noman K, Masood S, Chauhan S, Gupta A, Kumar S, Kumar D. Multimodality approach to gallbladder cancer: our experience at a tertiary care centre in Northern India Hpb. 20: S711. DOI: 10.1016/J.Hpb.2018.06.1423 |
0.376 |
|
| 2018 |
Chauhan S, Kumar S, Masood S, Pandey A, Kumar D. Does palliation of jaundice by PTBD improve the physical quality of life in patients with inoperable gall bladder cancer and surgical obstructive jaundice (SOJ)? Hpb. 20: S710-S711. DOI: 10.1016/J.Hpb.2018.06.1422 |
0.344 |
|
| 2017 |
Sahay P, Ganju A, Almabadi HM, Ghimire HM, Yallapu MM, Skalli O, Jaggi M, Chauhan SC, Pradhan P. Quantification of photonic localization properties of targeted nuclear mass density variations: application in cancer stage detection. Journal of Biophotonics. PMID 29222925 DOI: 10.1002/Jbio.201700257 |
0.413 |
|
| 2017 |
Hafeez BB, Ganju A, Sikander M, Kashyap VK, Hafeez ZB, Chauhan N, Malik S, Massey AE, Tripathi MK, Halaweish FT, Zafar N, Singh MM, Yallapu MM, Jaggi M, Chauhan SC. Ormeloxifene suppresses prostate tumor growth and metastatic phenotypes via inhibition of oncogenic β-catenin signaling and EMT progression. Molecular Cancer Therapeutics. PMID 28615299 DOI: 10.1158/1535-7163.Mct-17-0157 |
0.472 |
|
| 2017 |
Chowdhury P, Roberts AM, Khan S, Hafeez BB, Chauhan SC, Jaggi M, Yallapu MM. Magnetic Nanoformulations for Prostate Cancer. Drug Discovery Today. PMID 28526660 DOI: 10.1016/J.Drudis.2017.04.018 |
0.446 |
|
| 2017 |
Karuri AR, Kashyap VK, Yallapu MM, Zafar N, Kedia SK, Jaggi M, Chauhan SC. Disparity in rates of HPV infection and cervical cancer in underserved US populations. Frontiers in Bioscience (Scholar Edition). 9: 254-269. PMID 28410118 DOI: 10.2741/S486 |
0.343 |
|
| 2017 |
Kashyap VK, Khan S, Sikander M, Maher DM, Kumar SK, Sinha N, Yallapu MM, Zafar N, Jaggi M, Chauhan SC. Abstract IA30: Comorbidity factors associated with human papillomavirus infectivity: Implications in cervical cancer health disparity Cancer Epidemiology, Biomarkers & Prevention. 26. DOI: 10.1158/1538-7755.Disp16-Ia30 |
0.371 |
|
| 2017 |
Nagesh PKB, Chowdhury P, Chauhan SS, Hatami E, Khan S, Hafeez B, Chauhan SC, Jaggi M, Yallapu MM. Abstract LB-070: Nano self-assemblies of paclitaxel for breast cancer treatment Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-070 |
0.361 |
|
| 2017 |
Sikander M, Hafeez BB, Malik S, Ganju A, Halaweish FT, Yallapu MM, Chauhan SC, Jaggi M. Abstract 3224: Cucurbitacin D inhibits prostate tumor growth via targeting glucose metabolism Cancer Research. 77: 3224-3224. DOI: 10.1158/1538-7445.Am2017-3224 |
0.388 |
|
| 2017 |
Kashyap VK, Hafeez BB, Wang Q, Setua S, Massey A, Ganju A, Yallapu MM, Miller DD, Li W, Jaggi M, Chauhan SC. Abstract 3216: Attenuation of pancreatic tumor growth by a small molecule tubulin inhibitor Cancer Research. 77: 3216-3216. DOI: 10.1158/1538-7445.Am2017-3216 |
0.495 |
|
| 2017 |
Nagesh PK, Chowdhury P, Boya VN, Kashyap VK, Khan S, Hafeez BB, Zafar N, Behrman SW, Chauhan SC, Jaggi M, Yallapu MM. Abstract 1206: miR-205 replenishment in prostate cancer cells: A novel nanoparticle approach Cancer Research. 77: 1206-1206. DOI: 10.1158/1538-7445.Am2017-1206 |
0.406 |
|
| 2016 |
Boya VN, Lovett R, Setua S, Gandhi V, Nagesh PK, Khan S, Jaggi M, Yallapu MM, Chauhan SC. Probing mucin interaction behavior of magnetic nanoparticles. Journal of Colloid and Interface Science. 488: 258-268. PMID 27837716 DOI: 10.1016/J.Jcis.2016.10.090 |
0.327 |
|
| 2016 |
Sikander M, Hafeez BB, Malik S, Alsayari A, Halaweish FT, Yallapu MM, Chauhan SC, Jaggi M. Cucurbitacin D exhibits potent anti-cancer activity in cervical cancer. Scientific Reports. 6: 36594. PMID 27824155 DOI: 10.1038/Srep36594 |
0.502 |
|
| 2016 |
Setua S, Khan S, Yallapu MM, Behrman SW, Sikander M, Khan SS, Jaggi M, Chauhan SC. Restitution of Tumor Suppressor MicroRNA-145 Using Magnetic Nanoformulation for Pancreatic Cancer Therapy. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. PMID 27507554 DOI: 10.1007/S11605-016-3222-Z |
0.439 |
|
| 2016 |
Khan S, Sikander M, Ebeling MC, Ganju A, Kumari S, Yallapu MM, Hafeez BB, Ise T, Nagata S, Zafar N, Behrman SW, Wan JY, Ghimire HM, Sahay P, Pradhan P, ... Chauhan SC, et al. MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression. Oncogene. PMID 27321183 DOI: 10.1038/Onc.2016.218 |
0.412 |
|
| 2016 |
Nagesh PK, Johnson NR, Boya VK, Chowdhury P, Othman SF, Khalilzad-Sharghi V, Hafeez BB, Ganju A, Khan S, Behrman SW, Zafar N, Chauhan SC, Jaggi M, Yallapu MM. PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer. Colloids and Surfaces. B, Biointerfaces. 144: 8-20. PMID 27058278 DOI: 10.1016/J.Colsurfb.2016.03.071 |
0.463 |
|
| 2016 |
Zaman MS, Chauhan N, Yallapu MM, Gara RK, Maher DM, Kumari S, Sikander M, Khan S, Zafar N, Jaggi M, Chauhan SC. Curcumin Nanoformulation for Cervical Cancer Treatment. Scientific Reports. 6: 20051. PMID 26837852 DOI: 10.1038/Srep20051 |
0.526 |
|
| 2016 |
Kumari S, Khan S, Chauhan S, Jaggi M. Abstract 51: Role of MUC13 as non-hypoxic stimuli inducing HIF-1α in pancreatic cancer under normoxia Cancer Research. 76: 51-51. DOI: 10.1158/1538-7445.Am2016-51 |
0.477 |
|
| 2016 |
Khan S, Ebeling MC, Sikander M, Yallapu MM, Ise T, Nagata S, Behrman SW, Zafar N, Wan JY, Ghimire HM, Sahay P, Pradhan P, Jaggi M, Chauhan SC. Abstract 4592: MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression Cancer Research. 76: 4592-4592. DOI: 10.1158/1538-7445.Am2016-4592 |
0.462 |
|
| 2016 |
Ganju A, Hafeez BB, Halaweish F, Li W, Singh MM, Yallapu MM, Chauhan S, Jaggi M. Abstract 3862: Ormeloxifene, a novel pharmacological activator of PKD1 enhances docetaxel sensitivity in prostate cancer Cancer Research. 76: 3862-3862. DOI: 10.1158/1538-7445.Am2016-3862 |
0.499 |
|
| 2016 |
Sikander M, Hafeez BB, Halaweish FT, Yallapu MM, Jaggi M, Chauhan SC. Abstract 3081: Novel cucurbitacin analogue Cuc D exhibits potent anti-cancer activity in cervical cancer Cancer Research. 76: 3081-3081. DOI: 10.1158/1538-7445.Am2016-3081 |
0.508 |
|
| 2016 |
Hafeez BB, Kashyap VK, Boya VN, Ganju A, Sikander M, Yallapu MM, Jaggi M, Chauhan SC. Abstract 2208: Novel nanoparticle formulation of Plumbagin for pancreatic cancer treatment Cancer Research. 76: 2208-2208. DOI: 10.1158/1538-7445.Am2016-2208 |
0.553 |
|
| 2016 |
Boya VN, Lovett R, Satua S, Gandhi V, Nagesh PKB, Jaggi M, Chauhan SC, Yallapu MM. Abstract 2197: Mucopenetrating magnetic nanoparticles for drug delivery Cancer Research. 76: 2197-2197. DOI: 10.1158/1538-7445.Am2016-2197 |
0.409 |
|
| 2016 |
Kashyap VK, Khan S, Sikander M, Maher DM, Kumar S, Sinha N, Yallapu MM, Zafar N, Jaggi M, Chauhan SC. Abstract 1745: Comorbidity factors associated with human papillomavirus infectivity: Implications in cervical cancer health disparity Cancer Research. 76: 1745-1745. DOI: 10.1158/1538-7445.Am2016-1745 |
0.372 |
|
| 2016 |
Nagesh PKB, Johnson N, Boya VKN, Chowdhury P, Ganju A, Hafeez B, Khan S, Jaggi M, Chauhan SC, Yallapu MM. Abstract 1312: PSMA antibody functionalized docetaxel-loaded magnetic nanoparticles for prostate cancer therapy Cancer Research. 76: 1312-1312. DOI: 10.1158/1538-7445.Am2016-1312 |
0.511 |
|
| 2016 |
Setua S, Khan S, Yallapu MM, Sikander M, Behrman SW, Jaggi M, Chauhan SC. Abstract 1071: Mir-145 based magnetic nanoformulation for pancreatic cancer therapy Cancer Research. 76: 1071-1071. DOI: 10.1158/1538-7445.Am2016-1071 |
0.349 |
|
| 2016 |
Setua S, Behrman SW, Khan S, Yallapu MM, Jaggi M, Chauhan SC. 713 Restitution of Tumor Suppressor miR-145 Using Magnetic Nanoparticles Inhibits Pancreatic Cancer Gastroenterology. 150: S1189. DOI: 10.1016/S0016-5085(16)34023-9 |
0.4 |
|
| 2015 |
Khan S, Jaggi M, Chauhan SC. Revisiting stroma in pancreatic cancer. Oncoscience. 2: 819-20. PMID 26682261 |
0.396 |
|
| 2015 |
Sane S, Abdullah A, Nelson ME, Wang H, Chauhan SC, Newton SS, Rezvani K. Structural studies of UBXN2A and mortalin interaction and the putative role of silenced UBXN2A in preventing response to chemotherapy. Cell Stress & Chaperones. PMID 26634371 DOI: 10.1007/S12192-015-0661-5 |
0.444 |
|
| 2015 |
Yallapu MM, Nagesh PK, Jaggi M, Chauhan SC. Therapeutic Applications of Curcumin Nanoformulations. The Aaps Journal. 17: 1341-56. PMID 26335307 DOI: 10.1208/S12248-015-9811-Z |
0.319 |
|
| 2015 |
Rao P, Midde NM, Miller D, Chauhan S, Kumar A, Kumar S. Diallyl sulfide: Potential use in novel therapeutic interventions in alcohol, drugs, and disease mediated cellular toxicity by targeting cytochrome P450 2E1. Current Drug Metabolism. PMID 26264202 DOI: 10.2174/1389200216666150812123554 |
0.313 |
|
| 2015 |
El-Senduny FF, Badria FA, El-Waseef AM, Chauhan SC, Halaweish F. Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 26242260 DOI: 10.1007/S13277-015-3773-8 |
0.46 |
|
| 2015 |
Khan S, Chauhan N, Yallapu MM, Ebeling MC, Balakrishna S, Ellis RT, Thompson PA, Balabathula P, Behrman SW, Zafar N, Singh MM, Halaweish FT, Jaggi M, Chauhan SC. Nanoparticle formulation of ormeloxifene for pancreatic cancer. Biomaterials. 53: 731-43. PMID 25890768 DOI: 10.1016/J.Biomaterials.2015.02.082 |
0.516 |
|
| 2015 |
Khan S, Ebeling MC, Chauhan N, Thompson PA, Gara RK, Ganju A, Yallapu MM, Behrman SW, Zhao H, Zafar N, Singh MM, Jaggi M, Chauhan SC. Ormeloxifene suppresses desmoplasia and enhances sensitivity of gemcitabine in pancreatic cancer. Cancer Research. 75: 2292-304. PMID 25840985 DOI: 10.1158/0008-5472.Can-14-2397 |
0.432 |
|
| 2015 |
Yallapu MM, Chauhan N, Othman SF, Khalilzad-Sharghi V, Ebeling MC, Khan S, Jaggi M, Chauhan SC. Implications of protein corona on physico-chemical and biological properties of magnetic nanoparticles. Biomaterials. 46: 1-12. PMID 25678111 DOI: 10.1016/J.Biomaterials.2014.12.045 |
0.381 |
|
| 2015 |
Maher DM, Khan S, Nordquist JL, Ebeling MC, Bauer NA, Kopel L, Singh MM, Halaweish F, Bell MC, Jaggi M, Chauhan SC. Ormeloxifene efficiently inhibits ovarian cancer growth. Cancer Letters. 356: 606-12. PMID 25306892 DOI: 10.1016/J.Canlet.2014.10.009 |
0.533 |
|
| 2015 |
Gara RK, Kumari S, Ganju A, Yallapu MM, Jaggi M, Chauhan SC. Slit/Robo pathway: a promising therapeutic target for cancer. Drug Discovery Today. 20: 156-64. PMID 25245168 DOI: 10.1016/J.Drudis.2014.09.008 |
0.417 |
|
| 2015 |
Yallapu MM, Katti KS, Katti DR, Mishra SR, Khan S, Jaggi M, Chauhan SC. The roles of cellular nanomechanics in cancer. Medicinal Research Reviews. 35: 198-223. PMID 25137233 DOI: 10.1002/Med.21329 |
0.457 |
|
| 2015 |
Zaman MS, Chauhan N, Maher D, Gara R, Sikander M, Yallapu MM, Khan S, Jaggi M, Chauhan S. Abstract A57: Curcumin nanoformulation: A new therapeutic approach for cervical cancer treatment Cancer Epidemiology, Biomarkers & Prevention. 24. DOI: 10.1158/1538-7755.Disp14-A57 |
0.472 |
|
| 2015 |
Yallapu MM, Chauhan N, Khan S, Jaggi M, Ganju A, Maher DM, Ebeling MC, Chauhan SC. Abstract 5534: Novel pluronic F127-coated paclitaxel nanoparticles formulation for pancreatic cancer Cancer Research. 75: 5534-5534. DOI: 10.1158/1538-7445.Am2015-5534 |
0.544 |
|
| 2015 |
Sikander M, Khan S, Chauhan N, Zaman MS, Yallapu MM, Halaweish FT, Chauhan B, Malik S, Jaggi M, Chauhan SC. Abstract 4468: Anticancer activity of novel cucurbitacin analogue in pancreatic cancer Cancer Research. 75: 4468-4468. DOI: 10.1158/1538-7445.Am2015-4468 |
0.557 |
|
| 2015 |
Khan S, Chauhan N, Yallapu MM, Ebeling MC, Balakrishna S, Ellis RT, Thompson PA, Behrman SW, Zafar N, Singh MM, Halaweish FT, Jaggi M, Chauhan SC. Abstract 4392: Generation of a novel ormeloxifene nanoparticle formulation for pancreatic cancer treatment Cancer Research. 75: 4392-4392. DOI: 10.1158/1538-7445.Am2015-4392 |
0.534 |
|
| 2015 |
Khan S, Yallapu MM, Kumari S, Ganju A, Balakrishna S, Behrman SW, Zafar N, Jaggi M, Chauhan SC. Abstract 3676: Attenuation of pancreatic cancer stemness and growth by a novel magnetic nanoparticle formulation Cancer Research. 75: 3676-3676. DOI: 10.1158/1538-7445.Am2015-3676 |
0.527 |
|
| 2015 |
Ganju A, Gara R, Kumari S, Singh MM, Chauhan S, Jaggi M. Abstract 2072: Ormeloxifene attenuates wnt/β-catenin signaling in colon cancer cells by modulation of PKD1 and glycolytic pathways Cancer Research. 75: 2072-2072. DOI: 10.1158/1538-7445.Am2015-2072 |
0.53 |
|
| 2015 |
Zaman MS, Chauhan N, Gara RK, Maher D, Kumari S, Sikander M, Khan S, Yallapu MM, Jaggi M, Chauhan SC. Abstract 182: Smoking Carcinogen (BaP) enhances tumorigenic phenotypes of cervical cancer cells by modulation of HPV oncogenes and microRNA profiles Cancer Research. 75: 182-182. DOI: 10.1158/1538-7445.Am2015-182 |
0.38 |
|
| 2015 |
Gara RK, Kumari S, Khan S, Chauhan N, Ganju A, Chauhan SC, Jaggi M. Abstract 1001: Protein Kinase D1 induces autophagic cell death through activation of endoplasmic reticulum stress in prostate cancer cells Cancer Research. 75: 1001-1001. DOI: 10.1158/1538-7445.Am2015-1001 |
0.492 |
|
| 2014 |
Khan S, Ebeling MC, Zaman MS, Sikander M, Yallapu MM, Chauhan N, Yacoubian AM, Behrman SW, Zafar N, Kumar D, Thompson PA, Jaggi M, Chauhan SC. MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer. Oncotarget. 5: 7599-609. PMID 25277192 DOI: 10.18632/Oncotarget.2281 |
0.445 |
|
| 2014 |
Sundram V, Ganju A, Hughes JE, Khan S, Chauhan SC, Jaggi M. Protein kinase D1 attenuates tumorigenesis in colon cancer by modulating β-catenin/T cell factor activity. Oncotarget. 5: 6867-84. PMID 25149539 DOI: 10.18632/Oncotarget.2277 |
0.405 |
|
| 2014 |
Yallapu MM, Khan S, Maher DM, Ebeling MC, Sundram V, Chauhan N, Ganju A, Balakrishna S, Gupta BK, Zafar N, Jaggi M, Chauhan SC. Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer Biomaterials. 35: 8635-8648. PMID 25028336 DOI: 10.1016/J.Biomaterials.2014.06.040 |
0.79 |
|
| 2014 |
Ganju A, Yallapu MM, Khan S, Behrman SW, Chauhan SC, Jaggi M. Nanoways to overcome docetaxel resistance in prostate cancer. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 17: 13-23. PMID 24853766 DOI: 10.1016/J.Drup.2014.04.001 |
0.434 |
|
| 2014 |
Sane S, Abdullah A, Boudreau DA, Autenried RK, Gupta BK, Wang X, Wang H, Schlenker EH, Zhang D, Telleria C, Huang L, Chauhan SC, Rezvani K. Ubiquitin-like (UBX)-domain-containing protein, UBXN2A, promotes cell death by interfering with the p53-Mortalin interactions in colon cancer cells. Cell Death & Disease. 5: e1118. PMID 24625977 DOI: 10.1038/Cddis.2014.100 |
0.758 |
|
| 2014 |
Gupta BK, Maher DM, Ebeling MC, Stephenson PD, Puumala SE, Koch MR, Aburatani H, Jaggi M, Chauhan SC. Functions and regulation of MUC13 mucin in colon cancer cells. Journal of Gastroenterology. 49: 1378-91. PMID 24097071 DOI: 10.1007/S00535-013-0885-Z |
0.794 |
|
| 2014 |
Zaman MS, Chauhan N, Maher DM, Yallapu MM, Jaggi M, Chauhan SC. Abstract 5411: Curcumin nanoformulation: A new therapeutic approach for cervical cancer treatment Cancer Research. 74: 5411-5411. DOI: 10.1158/1538-7445.Am2014-5411 |
0.561 |
|
| 2014 |
Yallapu MM, Chauhan N, Othman SF, Khalilzad-Sharghi V, Jaggi M, Chauhan SC. Abstract 4459: Characterization of a novel magnetic nanoparticles formulation for cancer therapeutic applications Cancer Research. 74: 4459-4459. DOI: 10.1158/1538-7445.Am2014-4459 |
0.452 |
|
| 2014 |
Khan S, Ebeling M, Ansarullah A, Chauhan N, Gara RK, Jaggi M, Zhao H, Chauhan SC. Abstract 3603: A novel approach to enhance delivery and sensitivity of gemcitabine in pancreatic cancer by suppression of desmoplasia Cancer Research. 74: 3603-3603. DOI: 10.1158/1538-7445.Am2014-3603 |
0.473 |
|
| 2014 |
Chauhan N, Zaman MS, Yallapu MM, Maher DM, Ebeling MC, Chauhan SC, Jaggi M. Abstract 2753: Ormeloxifene inhibits cervical cancer cell growth through intrinsic apoptotic pathway Cancer Research. 74: 2753-2753. DOI: 10.1158/1538-7445.Am2014-2753 |
0.517 |
|
| 2014 |
Sikander M, Zaman MS, Chauhan N, Yallapu MM, Khan S, Halaweish FT, Chauhan B, Jaggi M, Chauhan SC. Abstract 2714: A multi-targeted approach for pancreatic cancer treatment by a novel cucurbitacin analogue Cancer Research. 74: 2714-2714. DOI: 10.1158/1538-7445.Am2014-2714 |
0.557 |
|
| 2014 |
Gara RK, Kumari S, Ganju A, Yallapu MM, Shah A, Khan S, Singh MM, Chauhan SC, Jaggi M. Abstract 1334: Induction of autophagy by ormeloxifene and mevastatin through Protein Kinase D1 in prostate cancer cells Cancer Research. 74: 1334-1334. DOI: 10.1158/1538-7445.Am2014-1334 |
0.51 |
|
| 2014 |
Ganju A, Sundram V, Miskimins K, Gara R, Khan S, Singh MM, Chauhan SC, Jaggi M. Abstract 1032: Ormeloxifene attenuates metastatic and glycolytic pathways in breast cancer cells Cancer Research. 74: 1032-1032. DOI: 10.1158/1538-7445.Am2014-1032 |
0.513 |
|
| 2013 |
Khan S, Ansarullah, Kumar D, Jaggi M, Chauhan SC. Targeting microRNAs in pancreatic cancer: microplayers in the big game. Cancer Research. 73: 6541-7. PMID 24204026 DOI: 10.1158/0008-5472.Can-13-1288 |
0.397 |
|
| 2013 |
Srivastava A, Goldberger H, Dimtchev A, Ramalinga M, Chijioke J, Marian C, Oermann EK, Uhm S, Kim JS, Chen LN, Li X, Berry DL, Kallakury BV, Chauhan SC, Collins SP, et al. MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214. Plos One. 8: e76994. PMID 24167554 DOI: 10.1371/Journal.Pone.0076994 |
0.302 |
|
| 2013 |
Gara RK, Sundram V, Chauhan SC, Jaggi M. Anti-cancer potential of a novel SERM ormeloxifene. Current Medicinal Chemistry. 20: 4177-84. PMID 23895678 DOI: 10.2174/09298673113209990197 |
0.495 |
|
| 2013 |
Yallapu MM, Ebeling MC, Khan S, Sundram V, Chauhan N, Gupta BK, Puumala SE, Jaggi M, Chauhan SC. Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment. Molecular Cancer Therapeutics. 12: 1471-80. PMID 23704793 DOI: 10.1158/1535-7163.Mct-12-1227 |
0.8 |
|
| 2013 |
Yallapu MM, Ebeling MC, Jaggi M, Chauhan SC. Plasma proteins interaction with curcumin nanoparticles: implications in cancer therapeutics. Current Drug Metabolism. 14: 504-15. PMID 23566382 DOI: 10.2174/1389200211314040012 |
0.415 |
|
| 2013 |
Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanomedicine: a road to cancer therapeutics. Current Pharmaceutical Design. 19: 1994-2010. PMID 23116309 DOI: 10.2174/138161213805289219 |
0.439 |
|
| 2013 |
Sundram V, Gara RK, Singh MM, Chauhan SC, Jaggi M. Abstract 5500: Ormeloxifene modulates beta-catenin/TCF pathway in colon cancer. Cancer Research. 73: 5500-5500. DOI: 10.1158/1538-7445.Am2013-5500 |
0.545 |
|
| 2013 |
Yallapu MM, Ebleling MC, Khan S, Chauhan N, Gupta BK, Sundram V, Jaggi M, Chauhan SC. Abstract 4503: Novel curcumin loaded magnetic nanoparticles for pancreatic cancer treatment. Cancer Research. 73: 4503-4503. DOI: 10.1158/1538-7445.Am2013-4503 |
0.805 |
|
| 2013 |
Khan S, Maher D, Ebeling M, Kumar D, Jaggi M, Chauhan SC. Abstract 4184: MicroRNA-145 targets MUC13 and suppresses invasion and metastasis of pancreatic cancer cells . Cancer Research. 73: 4184-4184. DOI: 10.1158/1538-7445.Am2013-4184 |
0.495 |
|
| 2013 |
Maher DM, Bell M, Schaefer A, Jaggi M, Chauhan SC. Abstract 3611: Benzo(a)pyrene exposure increases expression of HPV oncoproteins: a potential co-factor for increased cervical cancer among Northern Plains American Indian women. Cancer Research. 73: 3611-3611. DOI: 10.1158/1538-7445.Am2013-3611 |
0.397 |
|
| 2012 |
Zaman MS, Maher DM, Khan S, Jaggi M, Chauhan SC. Current status and implications of microRNAs in ovarian cancer diagnosis and therapy. Journal of Ovarian Research. 5: 44. PMID 23237306 DOI: 10.1186/1757-2215-5-44 |
0.424 |
|
| 2012 |
Gupta BK, Maher DM, Ebeling MC, Sundram V, Koch MD, Lynch DW, Bohlmeyer T, Watanabe A, Aburatani H, Puumala SE, Jaggi M, Chauhan SC. Increased expression and aberrant localization of mucin 13 in metastatic colon cancer. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 60: 822-31. PMID 22914648 DOI: 10.1369/0022155412460678 |
0.801 |
|
| 2012 |
Yallapu MM, Othman SF, Curtis ET, Bauer NA, Chauhan N, Kumar D, Jaggi M, Chauhan SC. Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications. International Journal of Nanomedicine. 7: 1761-79. PMID 22619526 DOI: 10.2147/Ijn.S29290 |
0.418 |
|
| 2012 |
Sundram V, Chauhan SC, Ebeling M, Jaggi M. Curcumin attenuates β-catenin signaling in prostate cancer cells through activation of protein kinase D1. Plos One. 7: e35368. PMID 22523587 DOI: 10.1371/Journal.Pone.0035368 |
0.496 |
|
| 2012 |
Chauhan SC, Ebeling MC, Maher DM, Koch MD, Watanabe A, Aburatani H, Lio Y, Jaggi M. MUC13 mucin augments pancreatic tumorigenesis. Molecular Cancer Therapeutics. 11: 24-33. PMID 22027689 DOI: 10.1158/1535-7163.Mct-11-0598 |
0.542 |
|
| 2012 |
Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discovery Today. 17: 71-80. PMID 21959306 DOI: 10.1016/J.Drudis.2011.09.009 |
0.44 |
|
| 2012 |
Yallapu MM, Dobberpuhl MR, Maher DM, Jaggi M, Chauhan SC. Design of curcumin loaded cellulose nanoparticles for prostate cancer Current Drug Metabolism. 13: 120-128. PMID 21892919 DOI: 10.2174/138920012798356952 |
0.519 |
|
| 2012 |
Patacsil D, Osayi S, Tran AT, Saenz F, Yimer L, Shajahan AN, Gokhale PC, Verma M, Clarke R, Chauhan SC, Kumar D. Vitamin E succinate inhibits survivin and induces apoptosis in pancreatic cancer cells. Genes & Nutrition. 7: 83-9. PMID 21842182 DOI: 10.1007/S12263-011-0242-X |
0.504 |
|
| 2012 |
Gupta BK, Maher DM, Ebeling MC, Lynch DW, Koch MD, Puumala SE, Aburatani H, Jaggi M, Chauhan SC. Abstract 5325: Role of MUC13 in colon cancer progression Cancer Research. 72: 5325-5325. DOI: 10.1158/1538-7445.Am2012-5325 |
0.808 |
|
| 2012 |
Sundram V, Radel S, Hughes J, Singh M, Chauhan SC, Jaggi M. Abstract 3806: Suppression of prostate cancer growth and invasion by a triphenyl ethylene compound ormeloxifene Cancer Research. 72: 3806-3806. DOI: 10.1158/1538-7445.Am2012-3806 |
0.478 |
|
| 2012 |
Maher DM, Stephenson P, Gupta BK, Bauer NA, Koch M, Eliason S, Jaggi M, Chauhan SC. Abstract 3589: Comparative expression profile of transmembrane mucin MUC1 in breast cancer from American Indian and Caucasian women Cancer Research. 72: 3589-3589. DOI: 10.1158/1538-7445.Am2012-3589 |
0.767 |
|
| 2012 |
Yallapu MM, Othman SF, Curtis ET, Chauhan N, Bauer NA, Jaggi M, Chauhan SC. Abstract 2893: Curcumin loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications Cancer Research. 72: 2893-2893. DOI: 10.1158/1538-7445.Am2012-2893 |
0.537 |
|
| 2012 |
Chauhan N, Maher DM, Yallapu MM, Ebeling MC, Jaggi M, Chauhan SC. Abstract 2882: Therapeutic effects of ormeloxifene on cervical cancer Cancer Research. 72: 2882-2882. DOI: 10.1158/1538-7445.Am2012-2882 |
0.478 |
|
| 2012 |
Maher DM, Bell M, Schaefer A, O'Donnell E, Jaggi M, Chauhan S. Abstract B75: Benzo(a)pyrene exposure increases expression of HPV oncoproteins: A potential co-factor for increased cervical cancer among Northern Plains American Indian women. Cancer Epidemiology, Biomarkers & Prevention. 21. DOI: 10.1158/1055-9965.Disp12-B75 |
0.397 |
|
| 2012 |
Maher DM, Gaster E, Stephenson P, Koch M, Eliason S, Jaggi M, Chauhan SC. Abstract B60: Role of MUC1 mucin in American Indian breast cancer health disparity. Cancer Epidemiology, Biomarkers & Prevention. 21. DOI: 10.1158/1055-9965.Disp12-B60 |
0.458 |
|
| 2011 |
Yallapu MM, Ebeling MC, Chauhan N, Jaggi M, Chauhan SC. Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes. International Journal of Nanomedicine. 6: 2779-90. PMID 22128249 DOI: 10.2147/Ijn.S25534 |
0.359 |
|
| 2011 |
Sundram V, Chauhan SC, Jaggi M. Emerging roles of protein kinase D1 in cancer. Molecular Cancer Research : McR. 9: 985-96. PMID 21680539 DOI: 10.1158/1541-7786.Mcr-10-0365 |
0.422 |
|
| 2011 |
Yellepeddi VK, Kumar A, Maher DM, Chauhan SC, Vangara KK, Palakurthi S. Biotinylated PAMAM dendrimers for intracellular delivery of cisplatin to ovarian cancer: role of SMVT. Anticancer Research. 31: 897-906. PMID 21498711 |
0.396 |
|
| 2011 |
Maher DM, Gupta BK, Nagata S, Jaggi M, Chauhan SC. Mucin 13: structure, function, and potential roles in cancer pathogenesis. Molecular Cancer Research : McR. 9: 531-7. PMID 21450906 DOI: 10.1158/1541-7786.Mcr-10-0443 |
0.795 |
|
| 2011 |
Yallapu MM, Jaggi M, Chauhan SC. Design and engineering of nanogels for cancer treatment. Drug Discovery Today. 16: 457-63. PMID 21414419 DOI: 10.1016/J.Drudis.2011.03.004 |
0.411 |
|
| 2011 |
Yallapu MM, Othman SF, Curtis ET, Gupta BK, Jaggi M, Chauhan SC. Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy. Biomaterials. 32: 1890-905. PMID 21167595 DOI: 10.1016/J.Biomaterials.2010.11.028 |
0.755 |
|
| 2011 |
Maher DM, Bell MC, O'Donnell EA, Gupta BK, Jaggi M, Chauhan SC. Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7. Molecular Carcinogenesis. 50: 47-57. PMID 21061268 DOI: 10.1002/Mc.20695 |
0.747 |
|
| 2011 |
Maher D, Gupta B, Ebeling M, Nagata S, Jaggi M, Chauhan S. MUC13 (mucin 13, cell surface associated) Atlas of Genetics and Cytogenetics in Oncology and Haematology. DOI: 10.4267/2042/44884 |
0.708 |
|
| 2011 |
Nordquist J, Maher DM, Ebeling M, Jaggi M, Chauhan SC. Abstract 4521: Ormeloxifene treatment inhibits growth of cisplatin-resistant ovarian cancer cells Cancer Research. 71: 4521-4521. DOI: 10.1158/1538-7445.Am2011-4521 |
0.49 |
|
| 2011 |
Yallapu MM, Othman SF, Curtis ET, Gupta BK, Jaggi M, Chauhan SC. Abstract 377: Multifunctional magnetic nanoparticles for theranostic applications Cancer Research. 71: 377-377. DOI: 10.1158/1538-7445.Am2011-377 |
0.778 |
|
| 2011 |
Hughes JE, Radel S, Sundram V, Jepperson TN, Koch MRD, Chauhan SC, Jaggi M. Abstract 2907: Protein Kinase D1 expression attenuates colon cancer progression Cellular and Molecular Biology. 71: 2907-2907. DOI: 10.1158/1538-7445.Am2011-2907 |
0.43 |
|
| 2011 |
Gupta BK, Maher DM, Ebeling M, Verma R, Lynch D, Koch M, Watanabe A, Aburatani H, Jaggi M, Chauhan SC. Abstract 1481: MUC13 expression enhances colon cancer progression Cancer Research. 71: 1481-1481. DOI: 10.1158/1538-7445.Am2011-1481 |
0.806 |
|
| 2010 |
Yallapu MM, Jaggi M, Chauhan SC. Scope of nanotechnology in ovarian cancer therapeutics. Journal of Ovarian Research. 3: 19. PMID 20691083 DOI: 10.1186/1757-2215-3-19 |
0.418 |
|
| 2010 |
Yallapu MM, Gupta BK, Jaggi M, Chauhan SC. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. Journal of Colloid and Interface Science. 351: 19-29. PMID 20627257 DOI: 10.1016/J.Jcis.2010.05.022 |
0.791 |
|
| 2010 |
Yallapu MM, Jaggi M, Chauhan SC. Poly(β-cyclodextrin)/curcumin self-assembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cells. Macromolecular Bioscience. 10: 1141-51. PMID 20572274 DOI: 10.1002/Mabi.201000084 |
0.43 |
|
| 2010 |
Yallapu MM, Jaggi M, Chauhan SC. beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids and Surfaces. B, Biointerfaces. 79: 113-25. PMID 20456930 DOI: 10.1016/J.Colsurfb.2010.03.039 |
0.418 |
|
| 2010 |
Yallapu MM, Maher DM, Sundram V, Bell MC, Jaggi M, Chauhan SC. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. Journal of Ovarian Research. 3: 11. PMID 20429876 DOI: 10.1186/1757-2215-3-11 |
0.554 |
|
| 2010 |
Yallapu MM, Jaggi M, Chauhan SC. Abstract LB-425: Design of ß-cyclodextrin-curcumin self-assembly: A new approach for enhanced curcumin delivery and therapeutic efficacy in prostate cancer cells Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-425 |
0.451 |
|
| 2010 |
Maher D, Yallapu MM, Sundram V, Bell MC, Jaggi M, Chauhan SC. Abstract 5381: Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth Cancer Research. 70: 5381-5381. DOI: 10.1158/1538-7445.Am10-5381 |
0.561 |
|
| 2010 |
Prakash P, Freiz M, Bohlmeyer T, Koch MRD, Chauhan SC, Jaggi M. Abstract 4621: Downregulation of Protein Kinase D1 in hepatocellular carcinoma (HCC): Potential as a diagnostic/prognostic molecular marker Cancer Research. 70: 4621-4621. DOI: 10.1158/1538-7445.Am10-4621 |
0.351 |
|
| 2010 |
Chauhan SC, Ebeling MC, Maher DM, Koch MD, Friez MH, Watanabe A, Aburatani H, Lio Y, Pandey KK, Jaggi M. Abstract 2358: MUC13 mucin augments pancreatic tumorigenesis Cancer Research. 70: 2358-2358. DOI: 10.1158/1538-7445.Am10-2358 |
0.536 |
|
| 2010 |
Sundram V, Chauhan SC, Jaggi M. Abstract 1892: Curcumin suppresses prostate cancer cells through modulation of β-catenin and protein kinase D1 Cancer Research. 70: 1892-1892. DOI: 10.1158/1538-7445.Am10-1892 |
0.494 |
|
| 2010 |
Maher DM, Bell MC, O'Donnell EA, Jaggi M, Chauhan SC. Abstract B66: Benzo(a)pyrene increases expression of HPV oncoproteins: A potential co-factor for increased cervical cancer among American Indian women living in the Northern Plains Cancer Epidemiology, Biomarkers & Prevention. 19. DOI: 10.1158/1055-9965.Disp-10-B66 |
0.408 |
|
| 2010 |
Nordquist J, Chauhan S, Maher D, Ebeling M, Bell M, Jaggi M. 257 Effects of Drug-X on cisplatin-resistant and cisplatin-sensitive ovarian cancer cells European Journal of Cancer Supplements. 8: 67. DOI: 10.1016/S1359-6349(10)71062-4 |
0.421 |
|
| 2009 |
Chauhan SC, Kumar D, Jaggi M. Mucins in ovarian cancer diagnosis and therapy. Journal of Ovarian Research. 2: 21. PMID 20034397 DOI: 10.1186/1757-2215-2-21 |
0.509 |
|
| 2009 |
Chauhan SC, Vannatta K, Ebeling MC, Vinayek N, Watanabe A, Pandey KK, Bell MC, Koch MD, Aburatani H, Lio Y, Jaggi M. Expression and functions of transmembrane mucin MUC13 in ovarian cancer. Cancer Research. 69: 765-74. PMID 19176398 DOI: 10.1158/0008-5472.Can-08-0587 |
0.537 |
|
| 2009 |
Jaggi M, Chauhan SC, Du C, Balaji KC. Bryostatin 1 modulates β-catenin subcellular localization and transcription activity through protein kinase D1 activation (Molecular Cancer Therapeutics (2008) 7, (2703-2712)) Molecular Cancer Therapeutics. 8: 1398. DOI: 10.1158/1535-7163.Mct-08-5-Cor1 |
0.368 |
|
| 2008 |
Jaggi M, Chauhan SC, Du C, Balaji KC. Bryostatin 1 modulates beta-catenin subcellular localization and transcription activity through protein kinase D1 activation. Molecular Cancer Therapeutics. 7: 2703-12. PMID 18765827 DOI: 10.1158/1535-7163.Mct-08-0119 |
0.382 |
|
| 2008 |
Mak P, Jaggi M, Syed V, Chauhan SC, Hassan S, Biswas H, Balaji KC. Protein kinase D1 (PKD1) influences androgen receptor (AR) function in prostate cancer cells. Biochemical and Biophysical Research Communications. 373: 618-23. PMID 18602367 DOI: 10.1016/J.Bbrc.2008.06.097 |
0.389 |
|
| 2008 |
Chaturvedi P, Singh AP, Chakraborty S, Chauhan SC, Bafna S, Meza JL, Singh PK, Hollingsworth MA, Mehta PP, Batra SK. MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells. Cancer Research. 68: 2065-70. PMID 18381409 DOI: 10.1158/0008-5472.Can-07-6041 |
0.476 |
|
| 2008 |
Chaturvedi P, Singh AP, Chakraborty S, Chauhan SC, Bafna S, Meza JL, Singh PK, Hollingsworth MA, Mehta PP, Batra SK. MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells (Cancer Research (April 1, 2008) 68(2065-2070)) Cancer Research. 68: 3549. DOI: 10.1158/0008-5472.Can-68-9-Cor3 |
0.508 |
|
| 2007 |
Chauhan SC, Vinayek N, Maher DM, Bell MC, Dunham KA, Koch MD, Lio Y, Jaggi M. Combined staining of TAG-72, MUC1, and CA125 improves labeling sensitivity in ovarian cancer: Antigens for multi-targeted antibody-guided therapy Journal of Histochemistry and Cytochemistry. 55: 867-875. PMID 17478446 DOI: 10.1369/Jhc.7A7213.2007 |
0.474 |
|
| 2007 |
Ponnusamy MP, Venkatraman G, Singh AP, Chauhan SC, Johansson SL, Jain M, Smith L, Davis JS, Remmenga SW, Batra SK. Expression of TAG-72 in ovarian cancer and its correlation with tumor stage and patient prognosis. Cancer Letters. 251: 247-57. PMID 17210225 DOI: 10.1016/J.Canlet.2006.11.025 |
0.488 |
|
| 2007 |
Singh AP, Chauhan SC, Andrianifahanana M, Moniaux N, Meza JL, Copin MC, van Seuningen I, Hollingsworth MA, Aubert JP, Batra SK. MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms. Oncogene. 26: 30-41. PMID 16799633 DOI: 10.1038/Sj.Onc.1209764 |
0.424 |
|
| 2006 |
Andrianifahanana M, Chauhan SC, Choudhury A, Moniaux N, Brand RE, Sasson AA, Pour PM, Batra SK. MUC4-expressing pancreatic adenocarcinomas show elevated levels of both T1 and T2 cytokines: potential pathobiologic implications. The American Journal of Gastroenterology. 101: 2319-29. PMID 17032197 DOI: 10.1111/J.1572-0241.2006.00871.X |
0.395 |
|
| 2006 |
Chauhan SC, Singh AP, Ruiz F, Johansson SL, Jain M, Smith LM, Moniaux N, Batra SK. Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125). Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 19: 1386-94. PMID 16880776 DOI: 10.1038/Modpathol.3800646 |
0.354 |
|
| 2006 |
Singh AP, Chauhan SC, Bafna S, Johansson SL, Smith LM, Moniaux N, Lin MF, Batra SK. Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas. The Prostate. 66: 421-9. PMID 16302265 DOI: 10.1002/Pros.20372 |
0.462 |
|
| 2005 |
Chauhan SC, Jain M, Moore ED, Wittel UA, Li J, Gwilt PR, Colcher D, Batra SK. Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49. European Journal of Nuclear Medicine and Molecular Imaging. 32: 264-73. PMID 15791435 DOI: 10.1007/S00259-004-1664-0 |
0.308 |
|
| 2004 |
Singh AP, Moniaux N, Chauhan SC, Meza JL, Batra SK. Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. Cancer Research. 64: 622-30. PMID 14744777 DOI: 10.1158/0008-5472.Can-03-2636 |
0.427 |
|
| 2004 |
Moniaux N, Varshney GC, Chauhan SC, Copin MC, Jain M, Wittel UA, Andrianifahanana M, Aubert JP, Batra SK. Generation and characterization of anti-MUC4 monoclonal antibodies reactive with normal and cancer cells in humans. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 52: 253-61. PMID 14729877 DOI: 10.1177/002215540405200213 |
0.36 |
|
| 2002 |
Standop J, Schneider MB, Ulrich A, Chauhan S, Moniaux N, Büchler MW, Batra SK, Pour PM. The pattern of xenobiotic-metabolizing enzymes in the human pancreas. Journal of Toxicology and Environmental Health. Part A. 65: 1379-400. PMID 12396872 DOI: 10.1080/00984100290071603 |
0.3 |
|
| Show low-probability matches. |